Sign inGet started

THREE ARCH PARTNERS III LP

Insider CIK 1256741 · CNCE 10% owner · ACRX 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ACRX ACELRX PHARMACEUTICALS INC J Other2018-05-212018-05-23126,153— $00SEC↗
ACRX ACELRX PHARMACEUTICALS INC J Other2018-05-212018-05-233,347,357— $00SEC↗
ACRX ACELRX PHARMACEUTICALS INC J Other2018-05-212018-05-23179,962— $00SEC↗
ACRX ACELRX PHARMACEUTICALS INC J Other2018-05-212018-05-235,713,569— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I S Sale2014-11-182014-11-20237,245$12.29 $2.92M540,375SEC↗
CNCE CONCERT PHARMACEUTICALS, I S Sale2014-11-182014-11-2012,755$12.29 $156.8K29,052SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion deriv2014-02-192014-02-2176,531— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion deriv2014-02-192014-02-211,897,959— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion deriv2014-02-192014-02-211,423,469— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion deriv2014-02-192014-02-2120,408— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion deriv2014-02-192014-02-21102,041— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion deriv2014-02-192014-02-21379,592— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion2014-02-192014-02-2113,545— $014,854SEC↗
CNCE CONCERT PHARMACEUTICALS, I P Buy2014-02-192014-02-2198,219$14.00 $1.38M777,620SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion2014-02-192014-02-2118,060— $032,914SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion2014-02-192014-02-21251,941— $0276,295SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion2014-02-192014-02-21335,922— $0612,217SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion2014-02-192014-02-2167,184— $0679,401SEC↗
CNCE CONCERT PHARMACEUTICALS, I P Buy2014-02-192014-02-215,281$14.00 $73.9K41,807SEC↗
CNCE CONCERT PHARMACEUTICALS, I C Conversion2014-02-192014-02-213,612— $036,526SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy2012-12-072012-12-112,364,705$3.31 $7.83M6,323,534SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy2012-12-072012-12-1152,213$3.31 $172.8K139,621SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy deriv2012-05-292012-05-3160,789$0.13 $7.9K60,789SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy deriv2012-05-292012-05-313,268$0.13 $4253,268SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy deriv2012-05-292012-05-31188,020$0.13 $24.4K188,020SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy deriv2012-05-292012-05-314,151$0.13 $5404,151SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy deriv2012-05-292012-06-064,151$0.13 $5404,151SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy deriv2012-05-292012-06-0660,789$0.13 $7.9K60,789SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy deriv2012-05-292012-06-063,268$0.13 $4253,268SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy deriv2012-05-292012-06-06188,020$0.13 $24.4K188,020SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy2012-05-292012-05-3167,543$3.40 $229.6K3,704,712SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy2012-05-292012-05-314,613$3.40 $15.7K87,408SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy2012-05-292012-05-31208,911$3.40 $710.3K3,958,829SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy2012-05-292012-05-313,631$3.40 $12.3K199,174SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy2012-05-292012-06-06208,911$3.40 $710.3K3,958,829SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy2012-05-292012-06-0667,543$3.40 $229.6K3,704,712SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy2012-05-292012-06-063,631$3.40 $12.3K199,174SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy2012-05-292012-06-064,613$3.40 $15.7K87,408SEC↗